Side of LogoAETC National Resource Center HomeSide of LogoTop of Banner
Search Web site
spacespace
space
spacespace

Efavirenz and Levonorgestrel

HIV Meds Quarterly Interactions, Winter 2010

A single-arm pharmacokinetic study investigated the interaction of efavirenz and levonorgestrel. HIV-seronegative women were given a single dose (0.75 mg) of levonorgestrel both before and after they had received efavirenz 600 mg daily for 14 days. Coadministration of efavirenz with levonorgestrel resulted in a 58% decrease in the levonorgestrel AUC and a 69% decrease in C min . Efavirenz levels were not different than those in a historical comparator.

Clinical Bottom Line

Efavirenz significantly decreases levonorgestrel levels. Pending the results of clinical studies, an additional or alternative form of birth control (or emergency contraception [Plan B]) should be used for women who take efavirenz.

For more information on interactions between ARVs and hormonal contraceptives, see HIV InSite's Database of Antiretroviral Drug Interactions .

References

  1. Carten M, Kiser J, Kwara A, et al. Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel, and efavirenz. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco. Abstract 934.